mPEG6-amine is a mid-length PEG linker offering terminal amine reactivity, commonly used in antibody-drug conjugation. Its PEG6 spacer enhances flexibility, solubility, and stability, contributing to improved pharmacokinetics of ADC therapeutics.
Structure of 184357-46-8
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
mPEG6-amine, a polyethylene glycol molecule featuring an amine group, showcases exceptional versatility in bioconjugation and drug delivery applications.
Drug Delivery Systems: The widespread integration of mPEG6-amine in formulating drug delivery systems underscores its pivotal role in augmenting the solubility and stability of therapeutic agents. By coupling drugs with mPEG6-amine, pharmaceutical entities can enhance drug pharmacokinetics and mitigate immunogenic responses.
Protein Modification: Within the domain of protein engineering, mPEG6-amine emerges as a coveted reagent for PEGylation, a transformative process entailing the attachment of polyethylene glycol chains to proteins. This modification confers heightened protein stability, reduced immunogenicity, and prolonged protein half-life within the physiological milieu. The amine moiety of mPEG6-amine facilitates precise and efficient protein surface conjugation, establishing it as an indispensable tool in the realm of therapeutic protein advancement.
Diagnostic Imaging: Harnessing mPEG6-amine for enhancing imaging agents serves as a testament to its profound impact on biocompatibility and circulation duration. Through the linkage of mPEG6-amine to imaging moieties, researchers can amplify the contrast and specificity of diagnostic instruments in medical imaging modalities like MRI and PET scans. This application assumes a pivotal role in ensuring precise disease diagnosis by yielding vivid and accurate imaging results.
Surface Modification: In the dynamic arena of biomaterials science, mPEG6-amine finds extensive utilization in surface modification initiatives pertaining to medical devices and implants. By coating surfaces with mPEG6-amine, researchers can effectively mitigate biofouling occurrences and cultivate enhanced biocompatibility. This strategic surface alteration hampers protein adsorption and cellular attachment, thereby reducing the risk of infection and inflammation.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00938 | mPEG10-amine | 1383658-09-0 | |
BADC-00986 | mPEG7-amine | 170572-38-0 | |
BADC-01648 | m-PEG12-amine | 1977493-48-3 | |
BADC-01067 | mPEG9-amine | 211859-73-3 | |
BADC-01115 | mPEG2-amine | 31576-51-9 | |
BADC-01149 | mPEG3-amine | 74654-07-2 | |
BADC-01166 | mPEG4-amine | 85030-56-4 | |
BADC-01167 | mPEG11-amine | 854601-60-8 | |
BADC-01177 | mPEG8-amine | 869718-81-0 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.